Special Issue "Marine Toxins in Non-traditional Vectors"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 6444
Interests: assessment of new marine toxin threats; cyanobacterial toxins; method development; reference materials; rapid testing methods; one health impacts
Special Issues, Collections and Topics in MDPI journals
Special Issue in Toxins: Paralytic Shellfish Toxins
Special Issue in Marine Drugs: A ‘One-Health Focus’ on Natural Aquatic Toxins
Marine biotoxins are produced naturally by certain species of algae and bacteria in a wide range of aquatic environments and can accumulate in marine invertebrates. Historically, the primary focus has been upon the presence of toxins in bivalve mollusc shellfish, with regulatory legislation in place for many decades throughout the world to reduce the risks of human poisoning following seafood consumption and to facilitate international trade. More evidence is building, however, for the uptake of marine toxins into non-bivalve molluscs, such as gastropods. Other marine phyla have also been associated with biotoxin presence, including echinoderms, arthropods, cnidarians, bryazoa and annelids, nematodes and flatworms. Furthermore, there are also reports of shellfish toxins being associated with uptake into fish, impacting animal health.
This Special Issue aims to focus on the interactions of non-bivalve marine organisms with harmful blooms of algae or bacteria and the consequent accumulation of biotoxins in their tissues. There is a growing need to focus not only on the presence of toxins in a wide range of pelagic and benthic organisms, but to also assess the impacts these processes may have on human food safety, animal health and ecosystem status (e.g., a One Health perspective).
Manuscript submission is encouraged for new findings of marine biotoxins in non-traditional vectors, including:
(1) detection in non-bivalve invertebrates and fish,
(2) studies describing food safety impacts or risks,
(3) assessment of toxin metabolism and/or toxin transformation in these organisms,
(4) impacts following toxin bioaccumulation on the health of high trophic level animals,
(5) application of new analytical approaches.
This Special Issue is dedicated to the memory of Dr Ann Abraham, USFDA.
Dr. Andrew Turner
Dr. Tim Harwood
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- marine biotoxins
- non-traditional vectors
- food safety
- one health
- market access
- metabolism and transformation
- harmful algal blooms